FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to oncology and can be used for prediction of cerebral metastases of pulmonary cancer The method involves the determination of prognostic indices by clinical anamnestic data If observing such prognostic indices as 55-60-year-old age in males, diagnosed peripheral adenocarcinoma or small cell carcinoma of right lung, T2-T3N2 (IIIA) stage, non-administered adjuvant therapy, the occurrence of cerebral metastases, mainly in the left brain is predicted within approximately 10 months after a primary tumour has been detected.
EFFECT: use of the invention allows individually predicting the probability and time of manifestation, localisation of cerebral metastases
1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREDICTING LUNG CANCER METASTASES | 2009 |
|
RU2411907C1 |
| METHOD FOR TREATING ONCOLOGICAL PATIENTS WITH METASTATIC CEREBRAL LESION | 2005 |
|
RU2290974C1 |
| METHOD OF PREDICTING DEVELOPMENT OF CEREBRAL METASTASES IN CASE OF LUNG CANCER IN WOMEN | 2009 |
|
RU2439579C2 |
| METHOD FOR PREDICTING BRAIN METASTATIC INJURIES GENERALIZATION | 2005 |
|
RU2300104C2 |
| METHOD FOR TREATING CEREBRAL METASTASES OF GENERALIZED SKIN MELANOMA | 2005 |
|
RU2286146C1 |
| METHOD FOR PREDICTING CEREBRAL METASTASIS LESION FOCI IN METASTATIC BRAIN INJURY PATIENTS | 2005 |
|
RU2300109C2 |
| METHOD FOR DETERMINING CHEMOTHERAPY EFFECTIVENESS IN TREATING PATIENTS FOR MALIGNANT BRAIN TUMORS | 2004 |
|
RU2271543C2 |
| METHOD FOR ASSAY OF TREATMENT EFFICACY OF PATIENTS WITH INTRACEREBRAL MALIGNANT TUMORS | 2003 |
|
RU2255745C2 |
| METHOD FOR DETECTING EXTRACRANIAL METASTASES IN METASTATIC BRAIN INJURY PATIENTS | 2005 |
|
RU2300110C2 |
| METHOD FOR SPECIFYING DIRECTIONALITY OF PATHOLOGICAL PROCESS IN LUNG CANCER | 2009 |
|
RU2440037C2 |
